Free Account Opening + AMC Free Demat
Loading...

Aurobindo Pharma Buyback 2024 vs Bajaj Consumer Care Buyback 2024

Comparision between Aurobindo Pharma Buyback 2024 and Bajaj Consumer Care Buyback 2024.

Buyback Details

Aurobindo Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Bajaj Consumer Care Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

  Aurobindo Pharma Limited Bajaj Consumer Care Limited
Logo Aurobindo Pharma Buyback 2024 Logo Bajaj Consumer Care Buyback 2024 Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹1 per share ₹1 per share
Buyback Price ₹1460 per share ₹290 per share
Issue Size 51,36,986 shares 57,41,000 shares
Issue Size (Amount) ₹750.00 Crores ₹166.49 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders5 Equity Shares out of every 41 Fully paid-up Equity Shares held on the Record Date.770,548.00
General Category for all other Eligible Shareholders4 Equity Shares out of every 531 Fully paid-up Equity Shares held on the Record Date.4,366,438.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders7 Equity Shares out of every 93 Fully paid-up Equity Shares held on the Record Date.861,150.00
General Category for all other Eligible Shareholders6 Equity Shares out of every 93 Fully paid-up Equity Shares held on the Record Date.4,879,850.00
Registrar Kfin Technologies Limited Kfin Technologies Limited
Lead Managers Axis Capital Limited Iifl Securities Ltd
Necessity of the buyback

The Buy-Back is being undertaken, inter-alia, for the following reasons:

  1. The buy-back will help the company reward its shareholders and enhance the overall return to shareholders.
  2. The buy-back is expected to improve earnings per share and other key ratios such as return on net worth and return on assets over a period of time;
  3. The buy-back is being implemented through the tender offer route as prescribed under the buyback regulations and would involve the allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved for small shareholders.

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares broadly in proportion to their shareholding.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit many public shareholders who would be classified as "small shareholders".
  3. The buyback may help in improving financial ratios like return on equity, by reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Buyback Timetable

Aurobindo Pharma Buyback 2024 and Bajaj Consumer Care Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2024 Buyback record date is Jul 30, 2024. Bajaj Consumer Care Buyback 2024 Buyback record date is Jul 02, 2024.

  Aurobindo Pharma Limited Bajaj Consumer Care Limited
Record Date Jul 30, 2024 Jul 02, 2024
Offer Open Date Aug 05, 2024 Jul 05, 2024
Offer Closure Date Aug 09, 2024 Jul 11, 2024
Last date for receipt of tender forms Aug 09, 2024 Jul 11, 2024
Finalisation of buyback Aug 16, 2024 Jul 16, 2024
Last Date for settlment of bids Aug 19, 2024 Jul 18, 2024
Last Date for extinguishment of shares Aug 28, 2024 Jul 19, 2024

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2024 and Bajaj Consumer Care Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Aurobindo Pharma Limited Bajaj Consumer Care Limited
Financial

Aurobindo Pharma Limited Financial Information (Restated Consolidated)

Aurobindo Pharma Limited's revenue increased by 17.55% and profit after tax (PAT) rose by 64.4% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets39,889.9933,921.72
Revenue29,559.2525,145.9723,775.84
Profit After Tax3,168.971,927.652,647.11
Net Worth28,091.0625,200.0423,808.63
Amount in ₹ Crore

Bajaj Consumer Care Limited Financial Information (Restated Consolidated)

Bajaj Consumer Care Limited's revenue increased by 3.09% and profit after tax (PAT) rose by 11.65% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets1,009.59949.64
Revenue1,028.79997.94918.60
Profit After Tax155.43139.22169.64
Net Worth830.58789.68809.63
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2024 1292.15 1109.30 1234.59
May-2024 1245.60 1097.50 1178.74
Apr-2024 1175.60 1066.05 1111.79

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
May-2024 271.00 229.80 241.92
Apr-2024 247.85 213.15 229.18
Mar-2024 240.75 206.00 222.00
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2024 1292.10 1109.45 1234.50
May-2024 1245.70 1097.10 1178.86
Apr-2024 1175.80 1069.30 1112.03

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
May-2024 271.00 229.80 241.90
Apr-2024 247.80 213.05 229.28
Mar-2024 240.60 205.50 222.11

Comments

Add a public comment...